| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-435-03 | 67877-435 | HUMAN PRESCRIPTION DRUG | Aripiprazole | Aripiprazole | TABLET | ORAL | 20190227 | N/A | ANDA | ANDA207105 | Ascend Laboratories, LLC | ARIPIPRAZOLE | 30 mg/1 | 30 TABLET in 1 BOTTLE (67877-435-03) |
| 67877-435-05 | 67877-435 | HUMAN PRESCRIPTION DRUG | Aripiprazole | Aripiprazole | TABLET | ORAL | 20190227 | N/A | ANDA | ANDA207105 | Ascend Laboratories, LLC | ARIPIPRAZOLE | 30 mg/1 | 500 TABLET in 1 BOTTLE (67877-435-05) |
| 67877-435-38 | 67877-435 | HUMAN PRESCRIPTION DRUG | Aripiprazole | Aripiprazole | TABLET | ORAL | 20190227 | N/A | ANDA | ANDA207105 | Ascend Laboratories, LLC | ARIPIPRAZOLE | 30 mg/1 | 10 BLISTER PACK in 1 CARTON (67877-435-38) / 10 TABLET in 1 BLISTER PACK (67877-435-33) |